Format

Send to

Choose Destination
Int J Cancer. 2014 Dec 15;135(12):2741-8. doi: 10.1002/ijc.28690. Epub 2014 Jan 13.

Emerging role of nanog in tumorigenesis and cancer stem cells.

Author information

1
Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH.

Abstract

Nanog is a transcription factor that is well-established as a key regulator of embryonic stem cell (ESC) maintenance. Recent evidence demonstrates that Nanog is dysregulated and intimately involved in promoting tumorigenesis in part through regulation of the cancer stem cell (CSC) population. Elevated Nanog is associated with poorer outcome in numerous epithelial malignancies. Nanog is enriched in CSCs and ablation of Nanog is sufficient to reduce the CSC pool. Nanog has also been implicated to promote chemoresistance and epithelial-mesenchymal transition (EMT). Insight into the Nanog signaling cascade, upstream regulators and downstream effectors, is beginning to emerge but remains to be fully elucidated. This review highlights the current literature on the emerging role of Nanog in tumorigenesis and CSCs.

KEYWORDS:

Nanog; cancer initiating cells; cancer stem cells; epithelial-mesenchymal transition; prognostic biomarkers

PMID:
24375318
PMCID:
PMC4065638
DOI:
10.1002/ijc.28690
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center